Skip to main content

Drug, Biotech Firms Beginning To Embrace Combinatorial Chemistry

Combinatorial Chemistry An emerging chemical discovery method is proving to be a fruitful source of research and job opportunities. The technique-called combinatorial chemistry-has spawned a wave of in-house pharmaceutical research and new collaboration between drug firms and biotech companies. Similar programs may also be on the horizon for agrochemical and materials science researchers. EUREKA: Ronald Zuckerman recalls Chiron's success Combinatorial chemistry shifts compound design from a

Written byKathryn Brown
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00

Combinatorial Chemistry An emerging chemical discovery method is proving to be a fruitful source of research and job opportunities. The technique-called combinatorial chemistry-has spawned a wave of in-house pharmaceutical research and new collaboration between drug firms and biotech companies. Similar programs may also be on the horizon for agrochemical and materials science researchers.


EUREKA: Ronald Zuckerman recalls Chiron's success
Combinatorial chemistry shifts compound design from a one-molecule-at-a-time approach to automated parallel synthesis. Starting with a useful compound or molecule, chemists can use robotics to spin that "lead" into thousands-or hundreds of thousands-of chemical variations. The resulting chemical diversity boosts the chance that a new compound will usefully react with a molecular target-say, a disease-causing molecule.

Drug and agrochemical industry leaders predict combinatorial chemistry will speed product discovery and open new doors for chemists. Pharmaceutical companies already are retraining and hiring chemists who can understand parallel processing, perform solid-state drug synthesis, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Published In

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems
Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Covaris
Using TCR Repertoire Sequencing to Advance Immunology Research

Using TCR Repertoire Sequencing to Advance Immunology Research

Miltenyi

Products

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo
Conceptual image of ice and frost.

The VAULT100 PRO: Inside the most advanced Stirling Ultracold ULT freezer ever built.

Stirling Ultracold logo